📣 More time to make your research shine! The abstract submission deadline has been extended to 22 November 2026. Submit your abstracts and be part of the conversation!
TODAY is the FINAL DAY to submit your abstract to HVS 2027! Abstract submissions close at 11:59 PM ET. Don’t miss your chance to bring your heart valve research to Amsterdam!
heartvalvesociety.org/meetin…
Two days to go! Put the finishing touches on your abstract and share your work with the global heart valve community at HVS 2027 in Amsterdam.
Deadline: October 25, 11:59 PM ET
heartvalvesociety.org/meetin…
ONE WEEK LEFT! Bring your discoveries, fresh perspectives and heart valve research to Amsterdam for HVS 2027.
Submit your abstract by October 25:
heartvalvesociety.org/meetin…
Your next collaboration could start in Amsterdam. Submit to #HVS2027 and connect with researchers and clinicians across the heart valve community.
10 days until the October 25 deadline!
heartvalvesociety.org/meetin…
Two weeks left! Give your research an international platform at HVS 2027 in Amsterdam. Accepted abstracts will appear in the Journal of the Heart Valve Society.
Deadline: October 25
heartvalvesociety.org/meetin…
From imaging to surgical innovation, bring your perspective to HVS 2027 in Amsterdam. Help advance the conversation on heart valve care!
Submit by October 25:
heartvalvesociety.org/meetin…
Bring your heart valve research to Amsterdam! Share your findings with the global valve community at HVS 2027, 14–17 April.
Submit by 25 October:
heartvalvesociety.org/meetin…
Heart Valve Society retweeted
.@HeartValveOrg & @WomenAs1 are pleased to announce our partnership to advance equity in heart valve disease.
Together, we will elevate women in the heart valve community, support leadership advancement & strengthen the science, innovation & care that shape patient outcomes.

ALT Graphic showing statistics within Heart Valve conditions and physicians. The gap is real. The opportunity is ours. Women as patients ~50% Aortic valve stenosis ~50% Mitral valve prolapse 30-40% Aortic valve regurgitation 60-70% Rheumatic heart valve disease Women as investigators & leaders ~18-20% Clinical trial principal investigators ~20% NIH R01 principal investigators ~1-5% Structural/valve operators 20-25% Leadership in valve disease (Society governance and guideline-writing committees) Progress is real. Parity is not. Let's build a field where talent determines the future.
6 sessions. 3 days. Hands-on innovation that matters.
Join us with Abbott, Boston Scientific, and Edwards to get up close with the latest in LAA closure, TAVI, and transcatheter valve therapies—because the future of structural heart isn’t just learned, it’s experienced.
Watch the latest HVS interview on “Growing Patients, Growing Valves: the Future of Partial Heart Transplantation” with Dr. David Kalfa, interviewed by Dr. Daniel Chaparro and Dr. Ishit Chauhan.
heartvalvesociety.org/interv…
#HVS #HeartValveSociety #PartialHeartTransplantation
🚨 Last call before prices go UP 🚨
Secure your spot at HVS 2026 now and save 💸
Don’t wait—onsite rates are right around the corner.
Dive into our annual meeting sessions on aortic, mitral, and potpourri topics. Cutting-edge insights, expert speakers, and fresh perspectives—don’t miss out and join us in Chicago during HVS 2026! 🩺✨
🕛 Today’s your LAST chance for early bird registration at HVS 2026. Don’t let savings and science slip away—register before midnight! 🕛
Tomorrow is the last day to secure your housing for the annual meeting! Don’t miss your chance—reserve your room before the deadline closes.
👨⚕️ Residents & Fellows: Level up your skills at our dedicated session during HVS 2026 in Chicago, IL! Get hands-on experience and mentorship from leaders in the field.
⏰ Early bird registration for HVS 2026 is EXTENDED—but only for 1 more week! Don’t miss your shot at savings and science. Register now before time runs out! ⏰




















